Fluphenazine decanoate: Its steady-state pharmacologic profile and relationship to tardive dyskinesia
-
Add time:09/28/2019 Source:sciencedirect.com
A sensitive radioimmunoassay was developed to determine the steady-state, fixed-dose pharmacokinetic profile of fluphenazine decanoate in nine outpatients. To see if neuroleptic blood levels measured by this assay correlated with a clinical event, we performed a cross-sectional study of fluphenazine blood levels in 11 patients with and 17 patients without tardive dyskinesia. The results do not support the hypothesis that fluphenazine decanoate serum levels correlate with TD occurrence.
We also recommend Trading Suppliers and Manufacturers of fluphenazine sulfoxide (cas 1674-76-6). Pls Click Website Link as below: cas 1674-76-6 suppliers
Prev:Short communicationFluphenazine hydrochloride radical cation assay: A new, rapid and precise method to determine in vitro total antioxidant capacity of fruit extracts
Next:Fluphenazine Enanthate) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research ArticlesBiological Disposition and Metabolic Fate of Fluphenazine-14C in the Dog and Rhesus Monkey09/30/2019
- Fluphenazine Enanthate09/29/2019
- Short communicationFluphenazine hydrochloride radical cation assay: A new, rapid and precise method to determine in vitro total antioxidant capacity of fruit extracts10/01/2019
- Distribution of fluphenazine and its metabolites in brain regions and other tissues of the rat09/27/2019
- Regular paperSensitive method for the simultaneous measurement of fluphenazine decanoate and fluphenazine in plasma by high-performance liquid chromatography with cuolometric detection09/26/2019
- Electrocatalysis of NADH oxidation using electrochemically activated fluphenazine on carbon nanotube electrode09/25/2019
- Radioimmunoassay for fluphenazine sulfoxide (cas 1674-76-6) in human plasma09/24/2019
